Quarterly report pursuant to Section 13 or 15(d)

9. STOCK-BASED COMPENSATION

v3.8.0.1
9. STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION

  9. STOCK-BASED COMPENSATION

 

The Company’s Amended 2013 Plan provides for the granting of stock options, restricted stock awards, RSU’s, stock bonus awards and performance-based awards. As of March 31, 2018, the Company had 2,513,000 of authorized unissued shares reserved and available for issuance upon exercise and conversion of outstanding awards under the Amended 2013 Plan.

 

The stock options are exercisable at no less than the fair market value of the underlying shares on the date of grant, and restricted stock and restricted stock units are issued at a value not less than the fair market value of the common stock on the date of the grant. Generally, stock options awarded are vested in equal increments ranging from two to four years on the annual anniversary date on which such equity grants were awarded. The stock options generally have a maximum term of 10 years.

 

The Company recognized Selling, General and Administration expenses of $1,035,153 and $1,186,291, relating to stock options and RSU’s issued to employees, officers, directors and consultants for the three months ended March 31, 2018 and 2017, respectively. As of March 31, 2018, total unrecognized compensation cost related to non-vested stock-based compensation arrangements granted to employees, officers, and directors was $2,150,643, which is expected to be recognized over a weighted-average period of 2.26 years.

 

The following table summarizes stock option activity for the Amended 2013 Plan during the three months ended March 31, 2018:

 

    Number of Shares     Weighted Average Exercise Price     Weighted Average Remaining Contract Term (Years)     Aggregate Intrinsic Value  
Outstanding - December 31, 2017     15,823,277     $ 0.46       8.54     $ 5,406,499  
Granted     6,669,000       0.40              
Exercised                        
Cancelled/Forfeited                        
Expired     (5,277 )     0.45              
Outstanding - March 31, 2018     22,487,000       0.45       8.33       2,573,402  
                                 
Total exercisable - March 31, 2018     15,187,459       0.49       7.79       1,645.367  
Total unvested - March 31, 2018     7,299,541       0.38       9.44       928,035  
Total vested or expected to vest - March 31, 2018     22,487,000       0.45       8.33       2,573,402  

 

The following table summarizes unvested stock options as of March 31, 2018:

 

    Number of
Shares
    Weighted
Average
Fair Value
Per Share on
Grant Date
 
Unvested stock options - December 31, 2017     3,738,615       0.36  
Granted     6,669,000       0.30  
Vested     (3,108,074 )     0.34  
Cancellations            
Unvested stock options - March 31, 2018     7,299,541       0.31  

 

The following table summarizes stock option activity outside of the Amended 2013 Plan during the three months ended March 31, 2018:

 

    Number of
Shares
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contract
Term
(Years)
    Aggregate
Intrinsic
Value
 
Outstanding - December 31, 2017     7,250,000     $ 0.37       8.78     $ 1,813,500  
Granted                        
Exercised                        
Forfeited                        
Expired                        
Outstanding - March 31, 2018     7,250,000       0.37       8.54       943,500  
                                 
Total exercisable - March 31, 2018     7,250,000       0.37       8.54       943,500  
Total unvested - March 31, 2018                        
Total vested or expected to vest - March 31, 2018     7,250,000       0.37       8.54       943,500  

 

As of March 31, 2018, there were 10,750,000 remaining unvested stock options granted outside of the Amended 2013 Plan which vest upon the completion of future performance conditions.